MENU

CGON CG Oncology Forecast, Technical & Fundamental Analysis

CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing its product candidate, cretostimogene grenadenorepvec, for patients with bladder cancer... Show more

Interact to see
Advertisement
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SNOY9.300.14
+1.53%
YieldMax SNOW Option Income Strategy ETF (SNOY)
EZJ59.91N/A
N/A
ProShares Ultra MSCI Japan (EZJ)
XLRE44.58-0.06
-0.13%
State Street Real Estate Select Sector SPDR ETF (XLRE)
BSL12.90-0.02
-0.15%
Blackstone Senior Floating Rate 2027 Term Fund
FIIG20.01-0.14
-0.69%
First Trust Intermediate Duration Investment Grade Corporate ETF (FIIG)

CGON and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CGON has been loosely correlated with MLTX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if CGON jumps, then MLTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGON
1D Price
Change %
CGON100%
-2.81%
MLTX - CGON
49%
Loosely correlated
-0.48%
ORKA - CGON
44%
Loosely correlated
+4.72%
SRRK - CGON
43%
Loosely correlated
-6.89%
IDYA - CGON
43%
Loosely correlated
-0.87%
LXEO - CGON
40%
Loosely correlated
-2.55%
More
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Industry
N/A
Address
400 Spectrum Center Drive
Phone
+1 949 409-3700
Employees
142
Web
https://www.cgoncology.com
CG Oncology (CGON) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com